$JKSM
Jacksam Corp Stock $jksm

$jksm Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000147793222001870 Filed on March 31, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$6.749M	$1.260M	$3.282M
YoY Change	105.64%	273.5%	-28.51%
Cost Of Revenue	$4.861M	$909.2K	$1.789M
YoY Change	171.72%	273.47%	-50.1%
Gross Profit	$1.888M	$350.5K	$1.493M
YoY Change	26.47%	273.57%	48.35%
Gross Profit Margin	27.98%	27.82%	45.5%
Selling, General & Admin	$1.252M	$534.6K	$788.5K
YoY Change	58.83%	-11.5%	-82.57%
% of Gross Profit	66.32%	152.56%	52.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.876K	$500.00	$9.932K
YoY Change	-81.11%	85.19%	828.22%
% of Gross Profit	0.1%	0.14%	0.67%
Operating Expenses	$2.526M	$534.6K	$1.882M
YoY Change	34.21%	-11.5%	-58.41%
Operating Profit	-$637.1K	-$184.2K	-$388.7K
YoY Change	63.92%	-63.91%	-88.95%
Interest Expense	$869.9K	$2.176M	$1.752M
YoY Change	-50.34%	-61.73%	-13710.8%
% of Operating Profit
Other Income/Expense, Net	$631.6K	$0.00	-$2.670M
YoY Change	-123.66%		18518.35%
Pretax Income	$1.694M	$2.337M	$1.536M
YoY Change	10.27%	-54.83%	-143.34%
Income Tax
% Of Pretax Income
Net Earnings	-$5.474K	$2.337M	-$3.059M
YoY Change	-99.82%	-54.83%	-13.72%
Net Earnings / Revenue	-0.08%	185.56%	-93.19%
Basic Earnings Per Share	$0.00		-$0.05
Diluted Earnings Per Share	$0.00	$33.80K	-$0.05
COMMON SHARES
Basic Shares Outstanding	72.13M shares		64.18M shares
Diluted Shares Outstanding	77.50M shares		64.18M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$344.8K	$489.6K	$489.6K
YoY Change	-29.57%	7.92%	7.92%
Cash & Equivalents		$489.6K
Short-Term Investments
Other Short-Term Assets	$8.600K	$148.5K	$148.5K
YoY Change	-94.21%	-40.98%	-40.98%
Inventory	$196.7K	$189.4K	$189.4K
Prepaid Expenses		$148.5K
Receivables	$591.2K	$292.8K	$292.8K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.141M	$1.120M	$1.120M
YoY Change	1.88%	11.97%	11.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.470K	$3.348K	$3.350K
YoY Change	-56.12%	-85.17%	-85.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.470K	$3.348K	$3.350K
YoY Change	-56.12%	-85.17%	-85.16%
TOTAL ASSETS
Total Short-Term Assets	$1.141M	$1.120M	$1.120M
Total Long-Term Assets	$1.470K	$3.348K	$3.350K
Total Assets	$1.143M	$1.124M	$1.124M
YoY Change	1.7%	9.83%	9.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$382.9K	$279.2K	$279.2K
YoY Change	37.15%	-19.73%	-19.73%
Accrued Expenses	$2.469M	$2.075M	$2.075M
YoY Change	19.0%	6.3%	6.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$789.0K	$918.4K	$918.4K
YoY Change	-14.09%	-24.1%	-24.31%
Total Short-Term Liabilities	$4.693M	$6.681M	$6.681M
YoY Change	-29.76%	23.48%	23.48%
LONG-TERM LIABILITIES
Long-Term Debt	$705.0K	$147.9K	$147.9K
YoY Change	376.57%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$705.0K	$147.9K	$147.9K
YoY Change	376.57%	-32.75%	-32.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.693M	$6.681M	$6.681M
Total Long-Term Liabilities	$705.0K	$147.9K	$147.9K
Total Liabilities	$5.398M	$6.829M	$6.829M
YoY Change	-20.96%	21.28%	21.28%
SHAREHOLDERS EQUITY
Retained Earnings		-$11.13M
YoY Change
Common Stock		$66.37K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.255M	-$5.705M	-$5.705M
YoY Change
Total Liabilities & Shareholders Equity	$1.143M	$1.124M	$1.124M
YoY Change	1.7%	9.83%	9.83%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	-$5.474K	$2.337M	-$3.059M
YoY Change	-99.82%	-54.83%	-13.72%
Depreciation, Depletion And Amortization	$1.876K	$500.00	$9.932K
YoY Change	-81.11%	85.19%	828.22%
Cash From Operating Activities	-$1.237M	-$186.6K	-$1.106M
YoY Change	11.91%	-62.25%	-51.85%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$846.4K
YoY Change			29086.21%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.093M	77.16K	$1.142M
YoY Change	-4.3%	-64.11%	-31.88%
NET CHANGE
Cash From Operating Activities	-$1.237M	-186.6K	-$1.106M
Cash From Investing Activities	$0.00	0.000	0.000
Cash From Financing Activities	$1.093M	77.16K	$1.142M
Net Change In Cash	-$144.7K	-109.4K	$35.94K
YoY Change	-502.79%	-60.81%	-105.79%
FREE CASH FLOW
Cash From Operating Activities	-$1.237M	-$186.6K	-$1.106M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74490147	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66366419	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	74490	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	66366	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6210414	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4708323	USD
CY2021Q4	jksm	Shares Payable SharesPayable	2222223	shares
CY2020Q4	jksm	Shares Payable Consisting Common Shares SharesPayableConsistingCommonShares	645192	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11130807	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11125333	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4931	USD
CY2021	dei	Auditor Location AuditorLocation	Plantation, FL
CY2021Q4	us-gaap	Assets Assets	1142764	USD
CY2020Q4	us-gaap	Assets Assets	1123625	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	641690	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	681439	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	171771	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1024466	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	701175	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	809242	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	87774	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	109104	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	325808	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1305106	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2264390	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1696223	USD
CY2021Q4	jksm	Subscription Payable SubscriptionPayable	499999	USD
CY2020Q4	jksm	Subscription Payable SubscriptionPayable	1055555	USD
CY2020Q4	jksm	Shares Payable SharesPayable	4421662	shares
CY2021Q4	jksm	Shares Payable Consisting Common Shares SharesPayableConsistingCommonShares	331600	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4692607	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6681135	USD
CY2021Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	705038	USD
CY2020Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	147942	USD
CY2021Q4	us-gaap	Liabilities Liabilities	5397645	USD
CY2020Q4	us-gaap	Liabilities Liabilities	6829077	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	jksm	Series A Preferred Stock SeriesAPreferredStock	259422	USD
CY2020Q4	jksm	Series A Preferred Stock SeriesAPreferredStock	0	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4514303	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5705452	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1142764	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1123625	USD
CY2021	us-gaap	Revenues Revenues	6749065	USD
CY2020	us-gaap	Revenues Revenues	3281935	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4860656	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1788817	USD
CY2021	us-gaap	Gross Profit GrossProfit	1888409	USD
CY2020	us-gaap	Gross Profit GrossProfit	1493118	USD
CY2021	us-gaap	Salaries And Wages SalariesAndWages	1273064	USD
CY2020	us-gaap	Salaries And Wages SalariesAndWages	1093268	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1252450	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	788527	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	2525514	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	1881795	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-637105	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-388677	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6154	USD
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1400011	USD
CY2020	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-1205196	USD
CY2021	us-gaap	Interest Expense InterestExpense	869902	USD
CY2020	us-gaap	Interest Expense InterestExpense	1751710	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	58642	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	64815	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2020	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	-53305	shares
CY2021	jksm	Loss On Settlement Of Notes Payable LossOnSettlementOfNotesPayable	160164	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	631631	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2669872	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3058549	USD
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7422	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12896	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3058549	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72126152	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64184514	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77495514	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64184514	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-4607543	USD
CY2020	jksm	Convertible Debt Imputed Interest ConvertibleDebtImputedInterest	604	USD
CY2020	jksm	Extinguishment Of Derivative Liability Due To Conversion ExtinguishmentOfDerivativeLiabilityDueToConversion	606048	USD
CY2020	jksm	Common Stock Issued For Debt Conversion Amount CommonStockIssuedForDebtConversionAmount	509259	USD
CY2020	jksm	Sale Of Common Stock Units Amount SaleOfCommonStockUnitsAmount	645192	USD
CY2020	jksm	Common Stock Issued For Deferred Finance Cost Amount CommonStockIssuedForDeferredFinanceCostAmount	199537	USD
CY2020	jksm	Shares Issued Under Share Lending Arrangement Amount SharesIssuedUnderShareLendingArrangementAmount	0	USD
CY2020	jksm	Shares Returned Under Share Lending Arrangement Amount SharesReturnedUnderShareLendingArrangementAmount	0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3058549	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5705452	USD
CY2021	jksm	Common Stock Issued For Debt Conversion Amount CommonStockIssuedForDebtConversionAmount	614198	USD
CY2021	jksm	Common Stock Issued For Deferred Finance Cost Amount CommonStockIssuedForDeferredFinanceCostAmount	172744	USD
CY2021	jksm	Sale Of Common Stock Units Amount SaleOfCommonStockUnitsAmount	187800	USD
CY2021	jksm	Common Stock And Warrants Issued For Settlement Of Notes Payable Amount CommonStockAndWarrantsIssuedForSettlementOfNotesPayableAmount	141118	USD
CY2021	jksm	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	15227	USD
CY2021	jksm	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	0	USD
CY2021	jksm	Extinguishment Of Derivative Liability Due To Conversion ExtinguishmentOfDerivativeLiabilityDueToConversion	72958	USD
CY2021	jksm	Shares Returned Under Share Lending Arrangement Amount SharesReturnedUnderShareLendingArrangementAmount	0	USD
CY2021	jksm	Issuance Of Series A Preferred Stock Amount IssuanceOfSeriesAPreferredStockAmount	0	USD
CY2021	jksm	Dividends On Series A Preferred Stock DividendsOnSeriesAPreferredStock	-7422	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4514303	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5474	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3058549	USD
CY2021	us-gaap	Depreciation Depreciation	1876	USD
CY2020	us-gaap	Depreciation Depreciation	9932	USD
CY2021	jksm	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	0	USD
CY2020	jksm	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	-399000	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	58642	shares
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	64815	shares
CY2021	us-gaap	Inventory Recall Expense InventoryRecallExpense	18000	USD
CY2020	us-gaap	Inventory Recall Expense InventoryRecallExpense	0	USD
CY2021	jksm	Imputed Interest ImputedInterest	0	USD
CY2020	jksm	Imputed Interest ImputedInterest	604	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	730371	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1654625	USD
CY2021	jksm	Derivative Gain Loss DerivativeGainLoss	-1400011	USD
CY2020	jksm	Derivative Gain Loss DerivativeGainLoss	1205196	USD
CY2021	jksm	Stock Based Compensation StockBasedCompensation	15227	USD
CY2020	jksm	Stock Based Compensation StockBasedCompensation	0	USD
CY2021	jksm	Gain On Settlement Of Notes Payables GainOnSettlementOfNotesPayables	-160163	USD
CY2020	jksm	Gain On Settlement Of Notes Payables GainOnSettlementOfNotesPayables	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-298334	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-187325	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-25289	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	418	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	139859	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	103080	USD
CY2021	jksm	Increasedecreaseinright Of Use Assets IncreasedecreaseinrightOfUseAssets	0	USD
CY2020	jksm	Increasedecreaseinright Of Use Assets IncreasedecreaseinrightOfUseAssets	9299	USD
CY2021	jksm	Increase Decrease In Accounts Payable And Accrued Expenses IncreaseDecreaseInAccountsPayableAndAccruedExpenses	540646	USD
CY2020	jksm	Increase Decrease In Accounts Payable And Accrued Expenses IncreaseDecreaseInAccountsPayableAndAccruedExpenses	40563	USD
CY2021	jksm	Right Of Use Liability RightOfUseLiability	0	USD
CY2020	jksm	Right Of Use Liability RightOfUseLiability	-9837	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-220000	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-852695	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-319517	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1237345	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1105696	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	570000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	634940	USD
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	905503	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	783365	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	43300	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1024024	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	591900	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	92925	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	104942	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	250000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	846400	USD
CY2021	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	252000	USD
CY2020	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1092596	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1141633	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-144749	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	35937	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	489560	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	453623	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	344811	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	489560	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	118732	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	59933	USD
CY2021	jksm	Common Stock Issued To Settle Convertible Notes Payable CommonStockIssuedToSettleConvertibleNotesPayable	614198	USD
CY2020	jksm	Common Stock Issued To Settle Convertible Notes Payable CommonStockIssuedToSettleConvertibleNotesPayable	1676234	USD
CY2021	jksm	Extinguishment Of Derivative Due To Warrant Exercise ExtinguishmentOfDerivativeDueToWarrantExercise	72958	USD
CY2020	jksm	Extinguishment Of Derivative Due To Warrant Exercise ExtinguishmentOfDerivativeDueToWarrantExercise	0	USD
CY2021	jksm	Derivative Liability Recognized At Issuance Of Warrants And Conversion Option DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption	493670	USD
CY2020	jksm	Derivative Liability Recognized At Issuance Of Warrants And Conversion Option DerivativeLiabilityRecognizedAtIssuanceOfWarrantsAndConversionOption	201208	USD
CY2021	jksm	Extinguishment Of Derivative To Conversion And Repayment ExtinguishmentOfDerivativeToConversionAndRepayment	0	USD
CY2020	jksm	Extinguishment Of Derivative To Conversion And Repayment ExtinguishmentOfDerivativeToConversionAndRepayment	390383	USD
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	172744	USD
CY2020	us-gaap	Restricted Stock Expense RestrictedStockExpense	199537	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1: Organization and Nature of Operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Jacksam Corporation dba Convectium is a technology company focused on developing and commercializing products of vaporizer cartridge filling & capping, pre-roll filling, and other automation systems. The Company’s product line primarily consisted of the 710 Shark cartridge filling machine, the 710 Captain cartridge capping machine, the “PreRoll-ER” pre-roll & cone filling machine, and cartridges. The Company’s customers are primarily businesses operating in jurisdictions that have some form of cannabis legalization. These businesses include medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors. The Company utilizes its direct sales force, website, strategic partners’ sales force, independent sales representatives, and a wide range of referral network to sell its products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was incorporated in the State of Nevada on September 21, 1989 under the name of Fulton Ventures, Inc. Since incorporated, the Company has engaged in a variety of businesses, but has been inactive since late 2014 through the Merger that closed on September 14, 2018. Since the Merger, the Company has been operated under the control of current management and continued to operate the business of Jacksam Corporation, described herein, as our sole business.</p>
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7422	USD
CY2021	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	846750	USD
CY2020	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2021	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-558765	USD
CY2020	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-3085549	USD
CY2021	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	72126152	USD
CY2020	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	64184514	USD
CY2021	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	1400000	USD
CY2020	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	0	USD
CY2021	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	3969136	USD
CY2020	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	0	USD
CY2021	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	USD
CY2020	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	USD
CY2021	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	77669683	USD
CY2020	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	64184514	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
CY2021	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	665169	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	366835	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	74000	USD
CY2021	jksm	Machine Sales MachineSales	5218158	USD
CY2020	jksm	Machine Sales MachineSales	1969693	USD
CY2021	jksm	Inventory Allowance InventoryAllowance	18800	USD
CY2020	jksm	Inventory Allowance InventoryAllowance	0	USD
CY2021	jksm	Performance Obligation PerformanceObligation	171771	USD
CY2020	jksm	Performance Obligation PerformanceObligation	1024466	USD
CY2021	jksm	Consumable Product Sales ConsumableProductSales	1530907	USD
CY2020	jksm	Consumable Product Sales ConsumableProductSales	1312242	USD
CY2021	us-gaap	Revenues Revenues	6749065	USD
CY2020	us-gaap	Revenues Revenues	3281935	USD
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	106872	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	56518	USD
CY2021	jksm	Summary Of Effect Of Potential Dilutive Issuances SummaryOfEffectOfPotentialDilutiveIssuances	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss attributable to common stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12,896</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,085,549</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,422</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative gain</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,400,011</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense associated with convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">846,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) for dilutive calculation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(558,765</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,085,549</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72,126,152</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,184,514</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,969,136</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of common stock warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding for diluted net income (loss) per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">77,669,683</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">64,184,514</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-12896	USD
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3085549	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1472	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3348	USD
CY2021	jksm	Depreciation Expense DepreciationExpense	1876	USD
CY2020	jksm	Depreciation Expense DepreciationExpense	9428	USD
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	11189056	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3969136	shares
CY2020Q4	jksm	Additional Common Stock Shares Issued AdditionalCommonStockSharesIssued	583333	shares
CY2020	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2777778	shares
CY2021	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	2222223	shares
CY2020	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	4421662	shares
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	USD
CY2021Q4	jksm	Less Accumulated Depreciation LessAccumulatedDepreciation	-19172	USD
CY2020Q4	jksm	Less Accumulated Depreciation LessAccumulatedDepreciation	-17296	USD
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2020Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2020	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2777778	shares
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	414930	shares
CY2021Q1	jksm	Warrants To Purchase Shares Of Common Stock WarrantsToPurchaseSharesOfCommonStock	207465	shares
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	109104	USD
CY2021Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	705038	USD
CY2020Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	147942	USD
CY2019Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	14835	USD
CY2021Q3	jksm	Investor Fees InvestorFees	5000	USD
CY2021Q3	jksm	Financing Fees FinancingFees	27500	USD
CY2021Q3	jksm	Common Stock To A Lender CommonStockToALender	843750	shares
CY2021Q1	jksm	Warrants To Purchase Shares Of Common Stock Exercise Price WarrantsToPurchaseSharesOfCommonStockExercisePrice	0.18
CY2021Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	55273	USD
CY2021Q1	jksm	Loss On Settlement Of Notes Payable LossOnSettlementOfNotesPayable	-137506	USD
CY2021	jksm	Amortization Of Debt Discount AmortizationOfDebtDiscount	723436	USD
CY2020	jksm	Amortization Of Debt Discount AmortizationOfDebtDiscount	1594924	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	641690	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	681439	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	914121	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	257046	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	121309	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	87774	USD
CY2021Q3	us-gaap	Deferred Purchased Power Costs DeferredPurchasedPowerCosts	100744	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	744444	USD
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1048524	USD
CY2021Q4	jksm	Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes	-43269	USD
CY2020Q4	jksm	Less Debt Discount And Deferred Finance Costs On Short Term Convertible Notes LessDebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes	-239282	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	701175	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	809242	USD
CY2020	jksm	Convertible Notes Payable1 ConvertibleNotesPayable1	444444	USD
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1333333	USD
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	6666661	shares
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	846400	USD
CY2020	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2525000	shares
CY2021Q4	jksm	Increased The Authorized Common Shares IncreasedTheAuthorizedCommonShares	230000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	jksm	Common Stock Designated CommonStockDesignated	200000000	shares
CY2021Q4	jksm	Preferred Stock Designated PreferredStockDesignated	30000000	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	250000	USD
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1388889	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.18
CY2021Q4	us-gaap	Share Price SharePrice	0.18
CY2021	jksm	Common Stock Unit Subscriptions CommonStockUnitSubscriptions	3868883	shares
CY2021	jksm	Shares Remaining To Be Issued SharesRemainingToBeIssued	2222223	shares
CY2021	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	3086420	shares
CY2021	us-gaap	Gain Loss On Fair Value Hedges Recognized In Earnings GainLossOnFairValueHedgesRecognizedInEarnings	58642	USD
CY2021	jksm	Share Issued For Professional Services ShareIssuedForProfessionalServices	143609	shares
CY2021	jksm	Fair Value Of Common Stock FairValueOfCommonStock	15227	USD
CY2021	jksm	Common Stock Issued For Cashless Exercise CommonStockIssuedForCashlessExercise	426136	shares
CY2021	jksm	Warrants Received WarrantsReceived	767045	shares
CY2020	jksm	Common Stock Issued Related To Conversion Of Convertible Notes Payable CommonStockIssuedRelatedToConversionOfConvertibleNotesPayable	2019401	shares
CY2020Q4	us-gaap	Share Price SharePrice	0.20
CY2020	jksm	Additional Common Stock AdditionalCommonStock	1896662	shares
CY2020Q4	jksm	Additional Share Subcription AdditionalShareSubcription	280554	shares
CY2020Q4	jksm	Additional Share Subcription Price AdditionalShareSubcriptionPrice	0.20
CY2020	us-gaap	Gain Loss On Fair Value Hedges Recognized In Earnings GainLossOnFairValueHedgesRecognizedInEarnings	53305	USD
CY2020	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	10566414	shares
CY2020	jksm	Fair Value Of Common Stock FairValueOfCommonStock	288667	USD
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2800000	shares
CY2021	jksm	Accrued Dividend AccruedDividend	7422	USD
CY2021Q4	jksm	Redemption Value Of Series A Preferred Stock RedemptionValueOfSeriesAPreferredStock	259422	USD
CY2020	jksm	Warrants Issued Due To Reset Provisions Aggregate Exercise Price WarrantsIssuedDueToResetProvisionsAggregateExercisePrice	562343	shares
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.0000	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.0103	pure
CY2020	jksm	Warrants Issued Due To Reset Provisions Weighted Average Exercise Price WarrantsIssuedDueToResetProvisionsWeightedAverageExercisePrice	0.35
CY2020	jksm	Warrants Issued With Common Stock Units Aggregate Number WarrantsIssuedWithCommonStockUnitsAggregateNumber	2211389	USD
CY2020	jksm	Warrants Issued With Common Stock Units Aggregate Exercise Price WarrantsIssuedWithCommonStockUnitsAggregateExercisePrice	631200	USD
CY2020	jksm	Warrants Issued With Common Stock Units Weighted Average Exercise Price WarrantsIssuedWithCommonStockUnitsWeightedAverageExercisePrice	0.001
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2100000	shares
CY2020	jksm	Aggregate Exercise Price Forfeited And Cancelled AggregateExercisePriceForfeitedAndCancelled	-2100	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.001
CY2020	jksm	Aggregate Number Ending AggregateNumberEnding	9378056	shares
CY2020	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	1921200	USD
CY2020	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.20
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2578045	shares
CY2021	jksm	Aggregate Exercise Price Granted AggregateExercisePriceGranted	562343	USD
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.41
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	767045	shares
CY2021	jksm	Aggregate Exercise Price Exercised AggregateExercisePriceExercised	337500	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2020	jksm	Aggregate Number Beginning AggregateNumberBeginning	5785714	shares
CY2020	jksm	Aggregate Exercise Price Beginning AggregateExercisePriceBeginning	1292100	USD
CY2020	jksm	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.01
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3480953	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.44
CY2021	jksm	Aggregate Number Ending AggregateNumberEnding	11189056	shares
CY2021	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	2646044	USD
CY2021	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.24
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y1M20D
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	192500	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	165000	USD
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	13750	USD
CY2021	jksm	Description For Extention Of Lease Term DescriptionForExtentionOfLeaseTerm	April 1, 2021 through February 28, 2022
CY2021	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	5000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	111043	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	61133	USD
CY2021	jksm	Cash Used In Operating Activities Related To Leases CashUsedInOperatingActivitiesRelatedToLeases	3855	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0027	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	631000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6086000	USD
CY2021Q4	jksm	Accrued Liabilities Other AccruedLiabilitiesOther	1696374	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1694212	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1536424	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1900	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1900	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1696112	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1538324	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1695904	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1538116	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.5850	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0004	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-2.407	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-0.1965	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	2.782	pure
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2000000	shares
CY2022Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	885000	USD
CY2022Q1	jksm	Closing Cost Of Stock Sold ClosingCostOfStockSold	115000	USD
CY2022Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	4000000	shares
CY2022Q1	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	0.20

Files In Submission

Name	View Source	Status
0001477932-22-001870-index-headers.html	Edgar Link	pending
0001477932-22-001870-index.html	Edgar Link	pending
0001477932-22-001870.txt	Edgar Link	pending
0001477932-22-001870-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jksm-20211231.xsd	Edgar Link	pending
jksm-20211231_cal.xml	Edgar Link	unprocessable
jksm-20211231_def.xml	Edgar Link	unprocessable
jksm-20211231_lab.xml	Edgar Link	unprocessable
jksm-20211231_pre.xml	Edgar Link	unprocessable
jksm_10k.htm	Edgar Link	pending
jksm_10k_htm.xml	Edgar Link	completed
jksm_ex311.htm	Edgar Link	pending
jksm_ex312.htm	Edgar Link	pending
jksm_ex321.htm	Edgar Link	pending
jksm_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JKSM
Jacksam Corp Stock $jksm

2021 Form 10-K Financial Statement

#000147793222001870 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM Jacksam Corp Stock $jksm

2021 Form 10-K Financial Statement

#000147793222001870 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM
Jacksam Corp Stock $jksm